Fig. 8
From: FK506 reduces albuminuria through improving podocyte nephrin and podocin expression in diabetic rats
Double immunostaining of ED-1/iNOS. The representative fields show renal expression of ED-1/iNOS as indicated, in normal rats (a), control diabetic (b), control diabetic + FK506 0.5 mg/kg (c) and diabetic + FK506 1.0 mg/kg (D). Magnification ×400